NMC Health Plc Revised Remuneration Policy - Publ. of Circular (8645R)
December 14 2016 - 8:11AM
UK Regulatory
TIDMNMC
RNS Number : 8645R
NMC Health Plc
14 December 2016
NMC Health plc
REVISED REMUNERATION POLICY - PUBLICATION OF CIRCULAR
London, 14 December 2016: NMC Health plc (NMC or the Company)
(LSE: NMC), the leading integrated private healthcare provider
operating across the United Arab Emirates, and one of the top
global providers of fertility treatment, announces circulation of a
notice to convene a General Meeting to consider the adoption of a
new remuneration policy with related explanatory circular (the
Circular).
The General Meeting (the GM) will be held on Thursday 29
December 2016 at 12:10 pm at the offices of Allen & Overy LLP,
One Bishops Square, London E1 6AD. The Notice of Meeting with
related explanatory circular and the associated Form of Proxy have
today been published and posted to shareholders. A copy of the
Circular and the accompanying Form of Proxy have also been
submitted to the National Storage Mechanism and will shortly be
available for inspection at www.Morningstar.co.uk/uk/NSM. In
addition, the Circular will be available to view on the Company's
website http://www.nmchealth.com/shareholder-information/ and
available for inspection at the offices of Allen & Overy LLP,
One Bishops Square, London E1 6AD.
Contacts:
Investors:
NMC
Simon Watkins, Group Company
Secretary +44 (0)20 3205 7313
Media:
FTI Consulting, London
Matthew Cole +44 (0)20 3727 1101
FTI Consulting, Gulf
Shane Dolan +971 (0)4 437 2100
About NMC
NMC Health plc group is the leading private sector healthcare
operator in the United Arab Emirates, with a nation-wide network of
hospitals and operations in the country since 1975. The group
currently operates or manages eight hospitals, two day-care patient
centres, nine medical centres and fifteen pharmacies. In addition,
the Group owns and operates Clinica Eugin in Barcelona, Spain - one
of the leading fertility treatment centres globally. In addition,
NMC acquired a 51% shareholding in Fakih IVF Group, the Middle East
market leader for in-vitro fertilisation (IVF) services. NMC also
owns and operates Americare Group, the leading home care provider
in the UAE as well as ProVita, the pioneering provider of long-term
medical care, also in the UAE. The enlarged company received almost
3.2m patients in 2015. The group is also a leading UAE supplier of
products and consumables across several key market segments, with
the major contribution coming from healthcare related products. NMC
Health plc group reported revenues of US$880.9m in 2015.
In April 2012 NMC Health plc was listed on the Premium Segment
of the London Stock Exchange. NMC Health plc is a constituent of
the FTSE 250 Index.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCUSRSRNKAUAAA
(END) Dow Jones Newswires
December 14, 2016 09:11 ET (14:11 GMT)
Nmc Health (LSE:NMC)
Historical Stock Chart
From Apr 2024 to May 2024
Nmc Health (LSE:NMC)
Historical Stock Chart
From May 2023 to May 2024